Summary
Dongdong Wang is a computational biologist and drug discovery leader with eight years of experience applying AI, physics-based simulation, and experimentation to tackle "undruggable" targets. As Co-President of Drug Discovery at DP Technology and Head of Computational Biology at Atombeat and formerly at Princeton, he led development of RiDYMO, an AI-for-Science hit discovery platform that has produced small molecules and macrocycles against challenging proteins such as c‑myc, β‑catenin, and GPX4. Trained with a Ph.D. from Fudan and a B.S. in Bioinformatics from Soochow University, he blends deep MD simulation expertise with practical translational goals to accelerate lead discovery beyond traditional drug-like space. Known for integrating molecular dynamics with ML to explore vast chemical space, he focuses on delivering rapid, experimentally validated hits that address unmet medical needs.
8 years of coding experience
1 year of employment as a software developer
B.S., Bioinformatics, B.S., Bioinformatics at Soochow University
Ph.D., Computational Biology, Ph.D., Computational Biology at Fudan University